Egypt is the most affected nation by hepatitis C virus (HCV) and needs a comprehensive
characterization of HCV epidemiology to inform the scale-up of treatment and prevention …

With regular blood transfusion and iron chelation therapy, most patients with thalassemia
major (BTM) now survive beyond the third decade of life. Liver disease is becoming an …

Abstract Background & Aims The prevention and control of HCV infection is complex and
challenging in terms of describing risk factors and modes of transmission. This meta …

The aim of the study was to assess the blood safety in India through prevalence in
thalassaemic population. Safety of the blood supply is a subject of great concern for all …

BACKGROUND: Beta Thalassemia is the most common chronic hemolytic anemia in Egypt
(85.1%) with an estimated carrier rate of 9-10.2%. Injury to the liver, whether acute or …

Purpose To identify, map, and synthesize the individual-level key associations and modes of
exposure for hepatitis C virus (HCV) infection in the Middle East and North Africa (MENA) …

Background Egypt has the highest prevalence of hepatitis C virus (HCV) infection. Anti-HCV
antibodies were detectable in 3% of children in Upper Egypt. Our aim was to evaluate the …

Background Thalassemia patients that are conventionally treated by a regular transfusion
regimen are exposed to blood born viral infections. The aim of this study was to investigate …

Materials and Methods HBsAg, anti-HBc, anti-HBs and anti-HCV were tested for 159 Syrian
multi-transfused patients by Enzyme-Linked Immunosorbent Assay (ELISA). Results Thirty …

Prevention programs for β-thalassemia based on molecular diagnosis of heterozygous
carriers and/or patients require the use of reliable mutation screening methods. The aim of …